Description
MyHep DVIR™ is a licensed generic of Sovaldi® + Daklinza® produced by Mylan Pharmaceuticals Ltd®, a US FDA certified manufacturer, in India. It’s a fixed-dose combination direct-acting antiviral (DAA) used to treat Chronic Hepatitis C across all genotypes. For most patients, 12 weeks of treatment is needed to reach cure.
Bottle Size : 28 Tablets (4 weeks supply)
Active Ingredients : Sofosbuvir 400 mg + Daclatasvir 60 mg
Produced by Mylan Pharmaceuticals®